83 related articles for article (PubMed ID: 8331687)
1. Reproducibility of methods relating to cyclophosphamide metabolic studies.
Phillipou G; Seaborn CJ; Raniolo E
J Natl Cancer Inst; 1993 Aug; 85(15):1249-51. PubMed ID: 8331687
[No Abstract] [Full Text] [Related]
2. Determination of cyclophosphamide metabolites by gas chromatography and thermionic specific detection. Interindividual differences in hepatic biotransformation of cyclophosphamide in man in vitro.
Sessink PJ; Vaes WH; van den Broek PH; Noordhoek J; Bos RP
J Chromatogr B Biomed Appl; 1995 Nov; 673(2):205-12. PubMed ID: 8611954
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
[No Abstract] [Full Text] [Related]
4. Comparative disposition of phosphoramide mustard and other cyclophosphamide metabolites in the mouse using the Salmonella/mutagenesis assay.
Suling WJ; Struck RF; Woolley CW; Shannon WM
Cancer Treat Rep; 1978 Sep; 62(9):1321-8. PubMed ID: 356985
[No Abstract] [Full Text] [Related]
5. Metabolism of cyclophosphamide by aldehyde dehydrogenases.
Agarwal DP; von Eitzen U; Meier-Tackmann D; Goedde HW
Adv Exp Med Biol; 1995; 372():115-22. PubMed ID: 7484368
[No Abstract] [Full Text] [Related]
6. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
[TBL] [Abstract][Full Text] [Related]
7. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide.
Zon G; Ludeman SM; Sweet EM; Egan W; Phillips LR
J Pharm Sci; 1982 Apr; 71(4):443-6. PubMed ID: 7086655
[TBL] [Abstract][Full Text] [Related]
8. Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometry.
Kalhorn TF; Howald WN; Cole S; Phillips B; Wang J; Slattery JT; McCune JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):105-13. PubMed ID: 16581318
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of oxazaphosphorines.
Sladek NE
Pharmacol Ther; 1988; 37(3):301-55. PubMed ID: 3290910
[No Abstract] [Full Text] [Related]
10. Cyclophosphamide metabolism in children.
Yule SM; Boddy AV; Cole M; Price L; Wyllie R; Tasso MJ; Pearson AD; Idle JR
Cancer Res; 1995 Feb; 55(4):803-9. PubMed ID: 7850793
[TBL] [Abstract][Full Text] [Related]
11. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
12. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
13. Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients.
Hadidi AH; Coulter CE; Idle JR
Cancer Res; 1988 Sep; 48(18):5167-71. PubMed ID: 3409242
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
16. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
17. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
Dirven HA; van Ommen B; van Bladeren PJ
Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
[TBL] [Abstract][Full Text] [Related]
18. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
19. Effects of enantiomeric homogeneity on the in vitro metabolism and in vivo anticancer activity of (+)- and (-)-cyclophosphamide.
Tsui FP; Brandt JA; Zon G
Biochem Pharmacol; 1979; 28(3):367-74. PubMed ID: 426853
[No Abstract] [Full Text] [Related]
20. In vitro alteration of canine renal allografts with cyclophosphamide metabolites.
Zincke H; Jardine I; Colvin M; Aydin G; Okiye SE
Transplant Proc; 1983 Jun; 15(2):1698-701. PubMed ID: 6349051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]